216 related articles for article (PubMed ID: 25673238)
1. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum.
Momose S; Weißbach S; Pischimarov J; Nedeva T; Bach E; Rudelius M; Geissinger E; Staiger AM; Ott G; Rosenwald A
Leukemia; 2015 Aug; 29(8):1789-91. PubMed ID: 25673238
[No Abstract] [Full Text] [Related]
2. Burkitt lymphoma and diffuse aggressive B-cell lymphoma.
Forteza-Vila J; Fraga M
Int J Surg Pathol; 2010 Jun; 18(3 Suppl):133S-135S. PubMed ID: 20484278
[No Abstract] [Full Text] [Related]
3. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Swerdlow SH
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
So CC; Yung KH; Chu ML; Wan TS
Int J Hematol; 2013 Oct; 98(4):478-82. PubMed ID: 23959583
[TBL] [Abstract][Full Text] [Related]
6. A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.
Soldini D; Montagna C; Schüffler P; Martin V; Georgis A; Thiesler T; Curioni-Fontecedro A; Went P; Bosshard G; Dehler S; Mazzuchelli L; Tinguely M
Ann Oncol; 2013 Jan; 24(1):193-201. PubMed ID: 22967991
[TBL] [Abstract][Full Text] [Related]
7. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2010 Jun; 28(2):53-6. PubMed ID: 19844983
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood and bone marrow findings in B-cell lymphoma, unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Ahmad OS; Fishlock K; May P; Kanfer E; Naresh KN
Am J Hematol; 2012 Feb; 87(2):201-2. PubMed ID: 22139902
[No Abstract] [Full Text] [Related]
9. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
Gebauer N; Bernard V; Feller AC; Merz H
Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
[TBL] [Abstract][Full Text] [Related]
10. Primary Burkitt's lymphoma of the breast without Epstein-Barr virus infection: A case report and literature review.
Wei J; Lin C; Xu C; Xi Q; Wang C
Indian J Pathol Microbiol; 2015; 58(4):546-9. PubMed ID: 26549090
[TBL] [Abstract][Full Text] [Related]
11. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
12. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
13. Burkitt lymphoma: analysis of the genome.
Dave S
Clin Adv Hematol Oncol; 2012 Jan; 10(1):54-5. PubMed ID: 22398809
[No Abstract] [Full Text] [Related]
14. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
Salaverria I; Siebert R
J Clin Oncol; 2011 May; 29(14):1835-43. PubMed ID: 21482997
[TBL] [Abstract][Full Text] [Related]
15. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
[TBL] [Abstract][Full Text] [Related]
17. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
Frick M; Dörken B; Lenz G
Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
[TBL] [Abstract][Full Text] [Related]
18. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of Burkitt lymphoma in the breast or ovary.
Elgaafary S; López C; Nagel I; Vater I; Bens S; Szczepanowski M; Aukema SM; Wagener R; Hopp L; Binder H; de Leval L; Klapper W; Siebert R
Leuk Lymphoma; 2021 Sep; 62(9):2120-2129. PubMed ID: 34165048
[TBL] [Abstract][Full Text] [Related]
20. Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.
Menguy S; Laharanne E; Prochazkova-Carlotti M; Gros A; Vergier B; Parrens M; Beylot-Barry M; Pham-Ledard A; Merlio JP
Am J Surg Pathol; 2020 Mar; 44(3):424-427. PubMed ID: 31764222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
